Disposition of 4000 shares by Stanley Peters of CONMED at 41.93 subject to Rule 16b-3
| CNMD Stock | USD 53.50 0.02 0.04% |
About 62% of CONMED's investor base is looking to short. The analysis of overall sentiment of trading CONMED stock suggests that many investors are alarmed at this time. The current market sentiment, together with CONMED's historical and current headlines, can help investors time the market. In addition, many technical investors use CONMED stock news signals to limit their universe of possible portfolio assets.
Filed transaction by CONMED Officer President As And Aet. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
Read at macroaxis.com
CONMED Fundamental Analysis
We analyze CONMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CONMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CONMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
CONMED is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
CONMED Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with CONMED stock to make a market-neutral strategy. Peer analysis of CONMED could also be used in its relative valuation, which is a method of valuing CONMED by comparing valuation metrics with similar companies.
Peers
CONMED Related Equities
| OFIX | Orthofix Medical | 13.46 | ||||
| IART | Integra LifeSciences | 2.03 | ||||
| GKOS | Glaukos Corp | 1.56 | ||||
| HAE | Haemonetics | 0.25 | ||||
| ICUI | ICU Medical | 0.80 | ||||
| MMSI | Merit Medical | 1.04 | ||||
| BRKR | Bruker | 7.63 |
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |